Clinical trial

Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder

NCT01467804

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Sertraline plus placebo of JWXYJN Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention JWXYJN plus placebo of Sertraline Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-11-01

PhaseNA

Conditions

Depressive Disorderverified · MONDO: depressive disorder

Interventions

Sertraline plus placebo of JWXYJNDRUG

JWXYJN plus placebo of SertralineDRUG

Sponsors & collaborators

Su Ruilead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01467804 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.